Canton Biologics Stock

Canton Biologics is a biologics contract development and manufacturing outsourcing company.

Sign up today and learn more about Canton Biologics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Canton Biologics Stock

Canton Biologics is a producer and designer of biologic drugs R&D. They provide services for biopharma, CDMO, and CRO. An online inquiry form is available on the company's website.

Funding History

July 2018$3.0M
September 2023$300M


Founder & CEO

Dr. Xiao Shen


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: